HALOZYME THERAPEUTICS, INC. financial data

Symbol
HALO on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 17 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 349% % -56%
Quick Ratio 55% % -53%
Debt-to-equity 558% % 6.7%
Return On Equity 93% % -33%
Return On Assets 14% % -37%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 118,017,000 shares -4.2%
Common Stock, Shares, Outstanding 117,782,000 shares -4.4%
Entity Public Float $4,500,000,000 USD -8.2%
Common Stock, Value, Issued $118,000 USD -4.1%
Weighted Average Number of Shares Outstanding, Basic 119,840,000 shares -5.5%
Weighted Average Number of Shares Outstanding, Diluted 123,904,000 shares -4.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,396,611,000 USD 38%
Research and Development Expense $70,034,000 USD -12%
Costs and Expenses $927,605,000 USD 100%
Operating Income (Loss) $469,006,000 USD -15%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $466,875,000 USD -16%
Income Tax Expense (Benefit) $149,986,000 USD 33%
Net Income (Loss) Attributable to Parent $316,889,000 USD -29%
Earnings Per Share, Basic 2.64 USD/shares -25%
Earnings Per Share, Diluted 2.56 USD/shares -25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $133,820,000 USD 16%
Accounts Receivable, after Allowance for Credit Loss, Current $426,273,000 USD 48%
Inventory, Net $176,475,000 USD 24%
Assets, Current $825,207,000 USD -24%
Deferred Income Tax Assets, Net $0 USD -100%
Property, Plant and Equipment, Net $44,442,000 USD 8.8%
Operating Lease, Right-of-Use Asset $37,695,000 USD 10%
Intangible Assets, Net (Excluding Goodwill) $981,467,000 USD 144%
Goodwill $580,360,000 USD 39%
Assets $2,525,323,000 USD 22%
Accounts Payable, Current $20,899,000 USD 104%
Accrued Liabilities, Current $156,193,000 USD 21%
Liabilities, Current $177,092,000 USD 27%
Deferred Income Tax Liabilities, Net $42,924,000 USD
Other Liabilities, Noncurrent $113,863,000 USD 108%
Liabilities $2,476,509,000 USD 46%
Accumulated Other Comprehensive Income (Loss), Net of Tax $18,092,000 USD -572%
Retained Earnings (Accumulated Deficit) $54,786,000 USD -85%
Stockholders' Equity Attributable to Parent $48,814,000 USD -87%
Liabilities and Equity $2,525,323,000 USD 22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $154,221,000 USD 19%
Net Cash Provided by (Used in) Financing Activities $3,321,000 USD -579%
Net Cash Provided by (Used in) Investing Activities $90,422,000 USD -9.4%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 117,782,000 shares -4.4%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $60,478,000 USD 31%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $136,421,000 USD 18%
Deferred Tax Assets, Valuation Allowance $878,000 USD -63%
Deferred Tax Assets, Gross $189,864,000 USD 78%
Operating Lease, Liability $34,569,000 USD 13%
Payments to Acquire Property, Plant, and Equipment $950,000 USD -73%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $294,968,000 USD -35%
Lessee, Operating Lease, Liability, to be Paid $40,491,000 USD 8.2%
Property, Plant and Equipment, Gross $77,601,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid, Year Two $9,005,000 USD 28%
Lessee, Operating Lease, Liability, to be Paid, Year One $11,277,000 USD 60%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5,922,000 USD -12%
Lessee, Operating Lease, Liability, to be Paid, Year Three $7,857,000 USD 27%
Deferred Tax Assets, Operating Loss Carryforwards $60,853,000 USD 193%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $26,865,000 USD 9.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,271,000 USD 15%
Operating Lease, Payments $7,700,000 USD 12%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $76,662,000 USD 7.9%
Depreciation, Depletion and Amortization $11,389,000 USD 11%
Deferred Tax Assets, Net of Valuation Allowance $188,986,000 USD 81%
Share-based Payment Arrangement, Expense $51,565,000 USD 19%
Interest Expense $18,726,000 USD -5.1%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%